Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 25:
26. The compound of claim 24, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is C3-C6 cycloalkyl, wherein the C3-C6 cycloalkyl is substituted by 1, 2, 3, 4, or 5 independently selected R2b substituents; and
at least one R2b is an independently selected C1-C6 alkyl substituent, wherein the C1-C6 alkyl substituent is optionally substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents.